al-Adrenergic receptors mediate vasoconstriction in the pulmonary and systemic vasculature.
In sheep the in vivo vasoconstrictor response to al-adrenergic stimulation is less in the pulmonary circulation compared with the systemic circulation of the fetus, the response increases in both vascular beds with fetal and postnatal development, and it decreases in the systemic vasculature with pregnancy. In an effort to determine the mechanisms underlying these differences, al-adrenergic receptor binding characteristics were determined by using [3H] prazosin in intrapulmonary and systemic (thoracic aorta) vascular smooth muscle (VSM) from late-gestation fetal lambs and from pregnant and nonpregnant ewes. al-Adrenergic receptor density was less in fetal intrapulmonary VSM that in fetal aortic VSM (12.4±1.5 versus 29.4 ±3.2 fmol/mg protein, p<0.05), and it was less (p<0.05) in the fetus compared with the pregnant ewe in both intrapulmonary and aortic VSM (51.0+5.2 and 76.5±5.9 fmol/mg protein, respectively). a1-Adrenergic receptor density in intrapulmonary VSM was similar in the pregnant and nonpregnant ewe (61.9±-7.2 fmol/mg protein), whereas in aortic VSM it was less (p<0.05) in pregnant ewes compared with nonpregnant ewes (101.0+ 5.5 fmol/mg protein). a1-Adrenergic receptor affinity was similar in all the VSM sources tested. 3-Adrenergic receptor density was studied for comparison, and it was similar in intrapulmonary and aortic VSM and unchanged in the fetus versus the pregnant ewe (18 14 .5+±2.9 fmol/mg protein in fetal intrapulmonary, fetal aortic, adult intrapulmonary, and adult aortic VSM, respectively). Thus, there are differences between vascular beds, maturational changes, and pregnancy-associated alterations in VSM a1-adrenergic receptor density that are specific to this adrenergic receptor type. It is speculated that these differences in receptor number may partly explain the disparate vasoconstrictor responses to al-adrenergic stimulation found in the pulmonary vasculature compared with the systemic vasculature, in the fetus compared with the adult, and in the pregnant state compared with the nonpregnant state. (Circulation Research 1990; 67:1193 -1200 Vasoconstriction is mediated by a,-adrenergic receptors in the pulmonary and systemic vasculature.' It has been shown that the vasomotor response to a1-adrenergic stimulation and/or inhibition varies between these two vascular beds, and there also appear to be alterations in In an effort to determine the mechanisms underlying these differences, the present study was designed to define a1-adrenergic receptor binding characteristics in intrapulmonary and systemic (thoracic aorta) vascular smooth muscle (VSM) from the lategestation fetal lamb and from the pregnant and nonpregnant ewe. These differences in response to ac-adrenergic receptor activation may be due to differences in receptor density, which has been shown to correlate with VSM sensitivity in some studies.1213 ,B-Adrenergic receptor binding characteristics were also examined to determine if the findings for a,-adrenergic receptors are common to other VSM adrenergic receptor types. Based on the results of the studies examining physiological parameters,2-11 the following hypotheses were tested:
1) a,-adrenergic receptor density is lower in pulmonary than in systemic VSM in the fetal lamb, 2) a,-adrenergic receptor density is lower in fetal compared with adult VSM, and 3) the density of a,-adrenergic receptors in VSM decreases with ovine pregnancy.
Materials and Methods Animal Model
The sheep has been used extensively by several groups of investigators2-11 in studies examining physiological parameters to assess a,-adrenergic mediation of both pulmonary and systemic vasomotor tone during fetal and postnatal development and during pregnancy. As such, it is an excellent animal model for the investigation of the variations in VSM aladrenergic receptor binding characteristics in different vascular beds with maturation and pregnancy. The VSM studied was obtained from three groups of mixed-breed sheep. They were fetal lambs at 125-140 days gestation (n = 16), with term being 144± 3 days, pregnant ewes at 125-140 days gestation (n = 15), and nonpregnant ewes (n = 17). All the pregnant ewes were multiparous and had singletons or twins, with the exception of one set of triplets. The ewes were housed in the Animal Resources Center of the University of Texas Southwestern Medical Center and were given standard animal chow and water ad libidum. The study protocol was approved by the Institutional Review Board for Animal Research.
Tissue Preparation
The pregnant ewe and fetus(es) were anesthetized with sodium pentobarbital (50 mg/kg) given intravenously to the ewe, and the fetus(es) was delivered by cesarean section. The thoracic contents of the ewe and fetus(es), including the thoracic aorta, were immediately removed en bloc and were placed into ice-cold 0.01 M phosphate-buffered saline (pH 7.4). The thoracic contents of nonpregnant ewes were removed in a similar manner. Further tissue preparation was performed in a cold room at 40 C. The pulmonary arterial tree was rapidly dissected from the lung parenchyma, the thoracic aorta was isolated, and both were placed in fresh ice-cold phosphatebuffered saline. Fat and connective tissue were removed, the adventitia was grossly dissected from the arteries until the homogeneous medial layer was reached, and the endothelium was scraped off with a cotton-tipped applicator. Removal of the endothelium was verified by demonstrating a lack of increase in cyclic GMP content with acetylcholine stimulation in arteries treated in the above manner compared with those with intact endothelium (authors' unpublished data).14 The remaining medial layer was the source of the VSM examined. To have sufficient quantities of VSM (particularly fetal) for the receptor binding studies with tritiated radioligand, the intrapulmonary VSM examined was obtained from the media of third to sixth generation pulmonary arteries, with the vast majority coming from the proximal branches. 15 The systemic VSM examined for comparison was obtained from the media of the thoracic aorta. The thoracic aorta was chosen for study because it also arises from the heart and is located in the thoracic cavity and because sufficient VSM can be obtained from it for the study of a,-adrenergic receptors in fetal systemic VSM. a1-Adrenergic Receptor Radioligand Binding Studies After the removal of the endothelium, the medial tissue was transferred into ice-cold 0.25 M sucrose buffer, pH 7.4, with 10 mM Tris base. Intrapulmonary or aortic VSM from one or two fetuses or from a single ewe (1.5-2.5 g wet wt) was placed in 20.0 ml buffer. The tissue was washed in the sucrose buffer twice, and the plasma membranes were prepared at 40 C by methods modified from those of Wei et al. 16 The tissue was minced with scissors and was homogenized twice with a Polytron (Brinkmann Instruments, Westbury, N.Y.) at setting No. 8 for 10 seconds. The homogenate was centrifuged at 40 C at 1,500g for 10 minutes, and the resulting supernatant was filtered through two layers of gauze and then centrifuged at 40 C at 100,OOOg for 30 minutes. The pellet formed was resuspended in 25 mM glycylglycine buffer, pH 7.4, yielding a protein concentration of 150-200 ,g/ml, as determined by a modification of the Lowry method.'7 The final membrane preparation was free of collagen, which was removed during the first centrifugation,16 and the protein concentration of the preparation was not influenced by elastin because it does not cross-react in the protein assay.
al-Adrenergic receptor binding assays were performed with 100 gl membrane preparation in a total volume of 150 gl of the 25 mM glycylglycine buffer.
The al-adrenergic receptor-specific radiolabeled antagonist [3H]prazosin was used. 18 [3H]Prazosin was added at concentrations ranging from 100 to 2,000 pM, in the presence or absence of 10-5 M phentolamine to distinguish nonspecific from specific binding. Time to equilibrium assays were performed with 150 pM [3H]prazosin, as were studies examining the affinity of the al-adrenergic receptors for agonists and antagonists (10-1o-10`-M l-norepinephrine, l-epinephrine, l-isoproterenol, prazosin, phentolamine, and yohimbine). Binding of [3H]prazosin to both intrapulmonary and aortic VSM membrane preparations reached equilibrium after 10 Figure 2 .22 Furthermore, agonist and antagonist displacement curves ( Figure 3 ) yielded an order of agonist potency of l-norepinephrine2l-epinephrine>l-isoproterenol and an order of antagonist potency of prazosin>phentolamine>yohimbine. This is characteristic of binding to an a,-adrenergic receptor.'8 The displacement curves illustrated in Figure 3 represent the mean values from three or four experiments performed in duplicate with each agonist and antagonist on membranes from intrapulmonary VSM from nonpregnant ewes. Identical displacement curves were obtained for aortic VSM membranes, and they were also similar for the three groups of sheep examined.
The densities of the ac-adrenergic receptors and the dissociation constants for [3H]prazosin binding in the intrapulmonary and aortic VSM from fetal and pregnant adult sheep are compared in Figure 4 . The percent specific binding at Kd was generally greater than 95%. a,-Adrenergic receptor density (Bm.) was lower in the intrapulmonary than in the aortic VSM from both the fetuses and the pregnant ewes; the density in intrapulmonary VSM was 42% and 67% of the density in aortic VSM from the two groups, respectively. In the intrapulmonary arteries, the receptor density in fetal VSM was 24% of the density in adult VSM. Similarly, in the thoracic aorta, receptor density in fetal VSM was 38% of the density in adult VSM. The dissociation constants were similar for all Figure 5 . Similar to the findings for the VSM from fetal and pregnant sheep, the density of receptors was less in the intrapulmonary arteries than in the thoracic aorta from the nonpregnant ewes, with the density in the intrapulmonary VSM 61% of that in the aortic VSM. The receptor density was similar in the intrapulmonary VSM from the pregnant and nonpregnant ewes. In the aortic VSM, however, receptor density was 25% less in the pregnant group compared with the nonpregnant group. The dissociation constants for the radioligand were similar in the intrapulmonary and aortic VSM from the pregnant and nonpregnant ewes. The results of these studies provide important new information regarding the possible mechanism(s) underlying the differences between the pulmonary and systemic vascular bed and the developmental and pregnancy-related changes in a1-adrenergic mediation of vasomotor tone. First, our finding that aradrenergic receptor density is less in the pulmonary compared with the systemic VSM of the third trimester fetal lamb is consistent with the observations of Nuwayhid et a12 that norepinephrine infusion results in a smaller increase in vascular resistance in the ovine fetal pulmonary compared with systemic circulation. In addition, these results are consistent with the work by Su et a13 demonstrating that the maximal contractile response to norepinephrine is less in arterial strips of ovine fetal main pulmonary artery compared with thoracic aorta. Regarding developmental changes, our observation that receptor density is less in fetal compared with adult VSM is consistent with the data of Nuwayhid and colleagues4 that indicates that there is a greater fall in pulmonary and systemic blood pressure in response to phenoxybenzamine in late-gestation compared with earlygestation fetuses, with the maximal response occurring in adult sheep. In addition, these findings agree with the work of these investigators showing that the rise in pulmonary and systemic vascular resistance with norepinephrine is increased with fetal and post- have demonstrated in ovine ear arteries that the maximal contraction generated with electrical stimulation of postganglionic neurons or with norepinephrine increases with development from 110 days of gestation through to adulthood. Lastly, regarding pregnancy-related changes, the finding that receptor density is decreased in the systemic VSM during pregnancy may partly explain the attenuated systemic response to norepinephrine and phenylephrine demonstrated by Magness and Rosenfeld'' to occur during ovine pregnancy. Studies of the uterine vasculature by Ford and coworkers2425 indicate that these changes in receptor density with pregnancy may be mediated by alterations in plasma progesterone and estrogen. Thus, our overall findings suggest that in the sheep the differences between the fetal pulmonary and systemic vascular bed and the developmental and pregnancy-related changes in the response to a1-adrenergic stimulation or inhibition may be related to variations in the density of VSM ar,-adrenergic receptors.
The relation of ar,-adrenergic receptor binding characteristics to the sensitivity of VSM to norepinephrine has been examined in a variety of animal models. Regarding receptor number, Oriowo and coworkers12 demonstrated in six different cat arteries that approximately 80% of the variation in the sensitivity to norepinephrine was attributable to differences in a1-adrenergic receptor number. In rat mesenteric artery, Colucci et al13 related changes in the sensitivity to norepinephrine after epinephrine administration to alterations in receptor number. Regarding receptor affinity for agonists, multiple studies have revealed the potential importance of this parameter in the determination of the sensitivity to norepinephrine, with several artery types in different species demonstrating significant covariance of tissue sensitivity and affinity of the a,-adrenergic receptor for norepinephrine.26 Although agonist affinities were not quantified in the present study, the similarity of the agonist displacement curves for the different artery types suggests that affinity did not differ in the groups examined. It is evident that the comparative roles of receptor density and affinity in the determination of tissue sensitivity may differ between vascular beds, between physiological and pathological states, and between species, with the present results suggesting that, in the sheep, receptor density may be a more important determinant than affinity. marked differences found in a1-adrenergic receptor density, it is doubtful that the demonstrated differences for the latter receptor type can be explained simply by differences between groups in the yield of the plasma membrane preparations. Instead, they most likely represent true differences between the artery types and between the developmental groups. Furthermore, the contrasts in the developmental patterns for /3-and a1-adrenergic receptor density may be reflective of differences in the factors mediating the ontogeny of these two receptor types. As noted earlier, our previous study23 suggests that the majority of /3-adrenergic receptors in ovine VSM are of the pJ2-adrenergic subtype. In general, the density of f32-adrenergic receptors in the cardiovascular system appears to be regulated humorally by circulating catecholamines, whereas the number of a1-adrenergic receptors seems to be regulated neuronally.27-29 Furthermore, the ontogeny of these two components of the sympathoadrenal system appears to be dissimilar in the sheep, in that plasma catecholamine concentrations have been found to be similar in fetal and adult sheep in some studies, whereas the neuronal regulation of vasomotor tone in both vascular beds appears to increase with fetal and postnatal development.4,30 As such, our contrasting results for the two receptor types may be explained in part by the thesis that the humoral mechanisms involved in ,82-adrenergic receptor development in ovine VSM are mature by late gestation, whereas the neuronal mediation of a1-adrenergic receptor density undergoes maturation both in utero and after birth. To our knowledge, the studies involving sympathectomy and adrenalectomy in fetal and developing sheep that would be necessary to test this hypothesis have not yet been performed.
In summary, a1-adrenergic receptor binding characteristics were determined in pulmonary and systemic VSM from late-gestation fetal lambs and pregnant and nonpregnant ewes in an effort to determine the mechanisms underlying the differences between vascular beds and the developmental and pregnancyrelated changes in a1-adrenergic mediation of vasomotor tone. The pulmonary VSM was derived from intrapulmonary arteries, and the systemic VSM was obtained from the thoracic aorta. In all groups studied, receptor density was lower in pulmonary compared with systemic VSM, receptor density in both VSM types was lower in the fetus compared with the adult, and receptor density in systemic VSM was decreased with pregnancy. There were no evident differences in affinity for agonists. Parallel studies of VSM /B-adrenergic receptors indicated that these changes are specific to the caq-adrenergic receptor. It is speculated that these differences in a1-adrenergic receptor density may partly explain the attenuated vasoconstrictor response to a-adrenergic stimulation in the pulmonary compared with the systemic vasculature of the fetal lamb, the increase in response in both vascular beds with fetal and postnatal development, and the attenuated systemic vasomotor response associated with pregnancy.
